Cholecystitis and Cholangitis during Continuous Renal Replacement Therapy in a Patient with Retroperitoneal Hemorrhage Requiring Large Amounts of Contrast Medium for the Assessment and Intervention-Reference-Cited by-同舟云学术

Cholecystitis and Cholangitis during Continuous Renal Replacement Therapy in a Patient with Retroperitoneal Hemorrhage Requiring Large Amounts of Contrast Medium for the Assessment and Intervention

Published:2022-08-15 Issue:16 Volume:61 Page:2533-2537
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Goto Kohsaku¹,Shimizu Yu¹,Kojima Toshiya¹,Takeda Norifumi¹,Fujiu Katsuhito¹,Komuro Issei¹

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/16/61_8518-21/_pdf

Reference11 articles.

1. 1. Masamichi Y, Jiro H, Tadahiro T, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis. J Hepatobiliary Pancreat Sci 25: 41-54, 2018.

2. 2. Kiriyama S, Kozaka K, Takada T, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci 25: 17-30, 2018.

3. 3. Yokoe M, Takada T, Mayumi T, et al. Japanese guidelines for the management of acute pancreatitis: Japanese guidelines 2015. J Hepatobiliary Pancreat Sci 22: 405-432, 2015.

4. 4. Waaler A, Svaland M, Fauchald P, Jakobsen JA, Kolmannskog F, Berg KJ. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure. Nephron 56: 81-85, 1990.

5. 5. Rendon CN, Judith LC, Jack EP, Michael EB. Contrast-enhanced CT of the liver and spleen: comparison of ionic and nonionic contrast agents. Am J Roentgenol 153: 973-976, 1989.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iohexol/iomeprol/iopamidol;Reactions Weekly;2022-09-10